Search Tag: Board of Directors
Quest Diagnostics Board of Directors Elects James E. Davis Chairman of the Board
2023 03 Mar
Quest Diagnostics, the world's leading provider of diagnostic information services announced that its Board of Directors elected James E. Davis, the company's Chief Executive Officer and President, to serve in the additional position of Chairman of the Board of Directors, effective April 1, 2023. "The Board carefully considered our governance structure... Read more
Pneumagen Appoints James Noble as Chairman of its Board of Directors
2023 06 Jan
Pneumagen, a clinical stage biotech company developing Neumifil, a broad-spectrum antiviral, intranasal drug for the prophylaxis and treatment of viral respiratory tract infections (RTIs), announces the appointment of James Noble as non-executive Chairman of its Board of Directors. James brings over 30 years of industry experience to the Board... Read more
TigerConnect Appoints Healthcare Executive Adrienne Kirby to Board of Directors
2022 30 Nov
TigerConnect, healthcare’s most powerful clinical collaboration platform, today announced the appointment of a healthcare executive, Adrienne Kirby, Ph.D., to its board of directors. With over four decades of experience guiding the strategic and operational development of large health systems, physician organizations, and outpatient services, Kirby... Read more
Gwen M. MacKenzie to Join Nemours Children’s Health Board of Directors
2022 31 Oct
The Nemours Children's Health Board of Directors has announced the election of Gwen M. MacKenzie to the Board, effective immediately. She has more than 30 years of experience leading complex health care organizations through transformation, strategic repositioning, and new service innovation. Ms. MacKenzie is a McKinsey & Company Senior Advisor... Read more
Theseus Pharmaceuticals Appoints Steven Stein, M.D. to Board of Directors
2022 19 Oct
Theseus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients through the discovery, development, and commercialization of transformative targeted therapies announced the appointment of Steven Stein , M.D. to its Board of Directors. "We are delighted to welcome Dr. Stein to the Theseus... Read more
Labcorp appoints Google Cloud executive Kirsten Kliphouse to its Board of Directors
2022 13 Oct
Labcorp, a leading global life sciences company announced that Kirsten Kliphouse, president of Americas, Google Cloud, has joined its Board of Directors as an independent member. Kliphouse brings decades of leadership experience honed at some of the world’s most-recognizable technology companies, as well as a proven passion for building teams and... Read more
Comar Announces Brian Larkin as President and Chief Executive Officer
2022 29 Sep
Comar has named Brian Larkin as its new President and Chief Executive Officer, succeeding Mike Ruggieri, who will transition to the Chairman role and remain on the Board of Directors. Under Mr. Ruggieri’s 15 years of leadership, Comar evolved from a single site family-owned business to a professionally backed, multi-national company with expanded customer... Read more
Everest Medicines Announces the Departure of CEO, Kerry Blanchard
2022 26 Aug
Everest Medicines , a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products to address critical unmet needs in Asia Pacific markets announced that Dr. Kerry Blanchard has resigned as Chief Executive Officer and as a member of the Board of Directors, effective immediately. He will remain as an advisor... Read more
Amgen Appoints Michael V. Drake to Board of Directors
2022 03 Aug
Amgen announced the appointment of Michael V. Drake, M.D., to its Board of Directors, effective immediately. Dr. Drake will also serve as a member of the Board's Corporate Responsibility and Compliance Committee and its Governance and Nominating Committee. Following the appointment of Dr. Drake, the Board will be composed of 13 directors, 12 of whom... Read more
Tevogen Bio Appoints Dr. Kendell R. Sprot to Corporate Advisory Board
2022 23 Jun
Tevogen Bio, a late-stage biotechnology company specializing in developing cell and gene therapies in oncology, neurology, and virology announced that its Board of Directors has appointed Kendell R. Sprott, M.D., J.D., to its Corporate Advisory Board. Most recently, Dr. Sprott served six years as President and CEO at Matheny Medical and Educational... Read more